🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PLX3397 is a selective inhibitor of Fms and Kit activity. The objective of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01090570
Treatments Being Tested
This phase 2, multicenter, two-part, open-label, single-arm study will be c...
Status
Completed
Location
Nagoya University Hospital
Start Date
2021-03-15
Trial ID
NCT04703322
Treatments Being Tested
PLX3397 is a selective inhibitor of Fms, Kit, and oncogenic Flt3 activity.T...
Status
Completed
Location
UCLA Jonsson Comprehensive Cancer Center
Start Date
2011-03-03
Trial ID
NCT01217229
Treatments Being Tested
The purpose of this research study is to test the safety of an investigatio...
Status
Terminated
Location
UCLA
Start Date
2013-11-05
Trial ID
NCT01826448
Treatments Being Tested
This study has two parts. Part 1 will evaluate how pexidartinib affects th...
Status
Completed
Location
HonorHealth
Start Date
2018-02-26
Trial ID
NCT03291288
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
Colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) are the...
Status
Completed
Location
Centre Léon Bérard
Start Date
2016-06
Trial ID
NCT02777710
Treatments Being Tested
The goal of this clinical research study is to learn how CGT9486 (fka PLX94...
Status
Completed
Location
Sylvester Comprehensive Cancer Center/ UMHC
Start Date
2015-03-06
Trial ID
NCT02401815
Treatments Being Tested
The purpose of this Phase I/II study is to evaluate safety, pharmacokinetic...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2017-01-31
Trial ID
NCT02975700
Treatments Being Tested
Background: \- Some people with cancer have solid tumors. Others have refr...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2015-04-29
Trial ID
NCT02390752
Treatments Being Tested